The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Eroxon sales certainly haven’t flopped …. Literally saying every minute or few being sold …. Amazon sales climbing again…Bizarre SP is so muted
Share price has flopped it needs erection
Fair point dosandonts, but i'm basing my view in part on barder's comments in the recent interview,where has talks about the royalty percentage and starts to suggest that it could have been higher with a different partner,but then stops himself and says that it is still a very good/perfectly acceptable percentage.sorry my take on what he said and certainly not verbatim.so i personally do doubt very much if it is at the level you suggest. perfectly happy to be proven wrong as it's just my opinion.just to restate, i'm not currently a holder, so just an interested bystander.
The only bone half of the so called investors have is within their heads.
Italian-Is it not unusual for FUM to be manufacturing it themselves through a 3rd party, rather than the distributor? If so deals will not be straight forward as not the norm. I’m predicting 20% min, otherwise surely it would have been easier to just license it out completely?
There was something a little strange about the china deal.there was a lot of conjecture at the time which i attributed to determined deramping, but it did fall through in the end . personally i don't think you can take the 50/50 split as anything other than sui generis for that particular deal. i think it is almost certain that royalty percentages for the recent deals are going to be in the 10 to 14% bracket,which would be normal and perfectly acceptable. fum is a very small player and is dependent on other to do the heavy lifting.
Bit strange that FUM BOD keep yapping on about commercial sensitivity, yet we’re happy to disclose the 50/50 profit sharing deal that fell through with the Asia market? I’m not sure how its in FUM’s interests anymore with the big players all signed up! It’s certainly not in my interests as a shareholder! Good news is that we will be selling to the Saudi’s very soon, a very profitable market.
Unlike its product the share price looks droopy, drop to 42p (close gap) then rise if sales support. Just my opinion.
You can't polish a turd, but you can roll it in glitter
Thank you for YESTERDAY’s suggestion BUCOLIC but tempting though it might be, I have too much regard for my RMWs to want to soil them.
Wasn’t it Boris who said “ You can’t polish a turd “ ?
For those of us who are hoping for sensational news regarding sales of EROXON when the Interims are published just bear in mind that there would only be a maximum of 2-3 months of sales not the full 6 months , even if COOPERS are prepared to disclose them, so it will only be a very basic indication as to how things have started off and up to the end of June.
Gla FUMSTERS.
Arturo.
Back over 3k per month
Ironically as i rwad this bb, the ads playing for viagra in the small video window.
Surely once the financial are released in September for the period up until the end of June and the units sold, It would make sense to disclose the financials of the deals done?? As I suspect the UK deal with being a new product to market & FUM being a tiny company, would not have been as favourable as subsequent deals done! IMO of course! Let’s also remember FUM are contracting out the manufacture as well, so these companies are just distributing it to the market, & therefore bypassing the middleman.
Actually, the connect product has a popup stand just in front of the shelf with Eroxon too. I reckon theyre really worried. Interesting. Especially as James Barder said he thought Eroxon was increasing the market rather than taking sales from these other brands
My local boots has put out a larger,new Cialis together shelf where they used to have the Eroxon shelf.
I'm seeing loads of ads on TV for these "together" products too.
I reckon they're worried about the Eroxon competition and are fighting back.
That's a good sign I'd say
The last recent couple of Eroxon reviews on the Belgium site Farmaline have been very positive! No idea re online sales as the site doesn’t do as boots online does ( or maybe it does )
I can see how all this selling and the SP not moving in the right direction can make you a nervous investor. Going by the evidence that we have, such as the RNS, visibility of sales on Boots and Amazon and the positive press - it means to me to hold on to what I have. This is a company a 12 people and information doesn't appear to leak easily (unlike other AIM companies). Like others have already said on here, the SP will only move up once we know more about the actual sales figures - not long now :-). Good luck.
I thought good news meant the SP would strengthen not in the case of FUM.
Good news today and the SP decreases further.
I am new to this I read the share chat daily,
Will FUM ever increase its Sp?
RNS is not visible on here for some reason? anyone wanting to view will need to go to Futura website directly.
The total Amazon reviews represent 1% to 2 % of likely total sales on Amazon of which 30% to 35% of those would definitely recommend. not sure how that’s viewed in grand scheme of things
Eroxon been flying on the Boots site last few days head to head with discounted Cialis
Regarding the fiddly ness of the tubes I agree it should be looked at but apparently the cap has a pin for opening
See one reviewer saying he had more success with the Eroxon blue pills. (Shrug)
Did like one suggestion by someone on here saying it would be better to sell it in a pump action bottle. The little tubes are a bit fiddley, especially trying to get that little silver foil cover off.
And the price breathtaking... More than £6 a time!
It is good to see how Eroxon is performing on Amazon, however the reviews are poor to put it mildly .
Eroxon now up to number 47 on Amazon's Health & Personal Care Best Sellers list......
https://www.amazon.co.uk/Best-Sellers-Health-Personal-Care/zgbs/drugstore/ref=zg_bsms_tab
Number 7 on the Movers and Shakers list with sales up 100%......
https://www.amazon.co.uk/gp/movers-and-shakers/drugstore/ref=zg_bs_tab
Number 2 in Male Condoms list......
https://www.amazon.co.uk/gp/bestsellers/drugstore/2758342031/ref=pd_zg_hrsr_drugstore
Was watching Britain’s most expensive homes on channel 4 this eve and when adverts came on included an advert for Eroxon.
We are a serious player in the ED market now and with a low market cap the breakout numbers look very impressive.